ConductScience.org, home

Paper39149142

Non-coding RNAs as therapeutic targets in cancer and its clinical application.

Leng X and 11 others. J Pharm Anal, 2024. Cited by 28 papers, by iCite.

Cite this record

ConductScience Library. Non-coding RNAs as therapeutic targets in cancer and its clinical application. Papers, record 39149142. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39149142

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Non-coding RNAs as therapeutic targets in cancer and its clinical application.
PubMed
Journal
J Pharm Anal
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
28
iCite
Relative citation ratio, by iCite
4.68, provisional
iCite
Revised in PubMed
2024-08-17
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Leng XXuejiao
2Zhang MMengyuan
3Xu YYujing
4Wang JJingjing
5Ding NNing
6Yu YYancheng
7Sun SShanliang
8Dai WWeichen
9Xue XXin
10Li NNianguang
11Yang YYe
12Shi ZZhihao

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References489

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132532962Circular RNA circZNF566 promotes hepatocellular carcinoma progression by sponging miR-4738-3p and regulating TDO2 expression.Cell Death Dis2020https://conductscience.org/library/papers/32532962PubMed
228435295Silencing CDR1as inhibits colorectal cancer progression through regulating microRNA-7.Onco Targets Ther2017https://conductscience.org/library/papers/28435295PubMed
317898713Tumour invasion and metastasis initiated by microRNA-10b in breast cancer.Nature2007https://conductscience.org/library/papers/17898713PubMed
433543830Circ-UBAP2 functions as sponges of miR-1205 and miR-382 to promote glioma progression by modulating STC1 expression.Cancer Med2021https://conductscience.org/library/papers/33543830PubMed
530621700The circRNA circAGFG1 acts as a sponge of miR-195-5p to promote triple-negative breast cancer progression through regulating CCNE1 expression.Mol Cancer2019https://conductscience.org/library/papers/30621700PubMed
634238213LncRNA UCA1 promotes development of gastric cancer via the miR-145/MYO6 axis.Cell Mol Biol Lett2021https://conductscience.org/library/papers/34238213PubMed
719818597MiRNA-29a regulates the expression of numerous proteins and reduces the invasiveness and proliferation of human carcinoma cell lines.Eur J Cancer2009https://conductscience.org/library/papers/19818597PubMed
832869873Gain of LINC00624 Enhances Liver Cancer Progression by Disrupting the Histone Deacetylase 6/Tripartite Motif Containing 28/Zinc Finger Protein 354C Corepressor Complex.Hepatology2021https://conductscience.org/library/papers/32869873PubMed
929449673The predictive and prognostic potential of plasma telomerase reverse transcriptase (TERT) RNA in rectal cancer patients.Br J Cancer2018https://conductscience.org/library/papers/29449673PubMed
1031062668M2-like tumor-associated macrophages-secreted EGF promotes epithelial ovarian cancer metastasis via activating EGFR-ERK signaling and suppressing lncRNA LIMT expression.Cancer Biol Ther2019https://conductscience.org/library/papers/31062668PubMed
1118474035RNAi mechanisms and applications.Biotechniques2008https://conductscience.org/library/papers/18474035PubMed
1232821115CircHIPK3 Promotes Clear Cell Renal Cell Carcinoma (ccRCC) Cells Proliferation and Metastasis via Altering of miR-508-3p/CXCL13 Signal.Onco Targets Ther2020https://conductscience.org/library/papers/32821115PubMed
1324379988Identification of differentially expressed long non-coding RNAs in human ovarian cancer cells with different metastatic potentials.Cancer Biol Med2013https://conductscience.org/library/papers/24379988PubMed
1419671678miR-93, miR-98, and miR-197 regulate expression of tumor suppressor gene FUS1.Mol Cancer Res2009https://conductscience.org/library/papers/19671678PubMed
1524813230Ovarian tumor-associated microRNA-20a decreases natural killer cell cytotoxicity by downregulating MICA/B expression.Cell Mol Immunol2014https://conductscience.org/library/papers/24813230PubMed
1624843008p50-associated COX-2 extragenic RNA (PACER) activates COX-2 gene expression by occluding repressive NF-κB complexes.Elife2014https://conductscience.org/library/papers/24843008PubMed
1731625175Exosome circ_0044516 promotes prostate cancer cell proliferation and metastasis as a potential biomarker.J Cell Biochem2020https://conductscience.org/library/papers/31625175PubMed
1831270953Circular RNA circABCC4 as the ceRNA of miR-1182 facilitates prostate cancer progression by promoting FOXP4 expression.J Cell Mol Med2019https://conductscience.org/library/papers/31270953PubMed
1931593800Reduction of circular RNA Foxo3 promotes prostate cancer progression and chemoresistance to docetaxel.Cancer Lett2020https://conductscience.org/library/papers/31593800PubMed
2030208739Roles of miR-200 family members in lung cancer: more than tumor suppressors.Future Oncol2018https://conductscience.org/library/papers/30208739PubMed

See all 489 referencesDownload CSV of references

Cited by22

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 28 citations.

PMIDTitleJournalYearIn PapersSource
42885288miR‑324‑5p in oncology: Molecular mechanisms and clinical outlook (Review).Oncol Rep2026https://conductscience.org/library/papers/42885288PubMed
42737737The hsa_circ_0084050/miR-373-3p Axis Controls Bone Sialoprotein-Induced ADAM9 Upregulation to Drive Lung Cancer Progression and Metastasis.Int J Mol Sci2026https://conductscience.org/library/papers/42737737PubMed
42348295A Primate-Specific lncRNA LINC01021 Contributes to Cellular and Organismal Aging via DAZAP1-Dependent Destabilization of RBMX.Aging Cell2026https://conductscience.org/library/papers/42348295PubMed
42246151LINC01117 promotes the malignant proliferation of lung adenocarcinoma by increasing HOXD8 mRNA stability.Mol Med Rep2026https://conductscience.org/library/papers/42246151PubMed
42035369Identification of hsa-miR-144-3p as a novel immunotherapeutic target for glioblastoma based on disulfidptosis-related analysis.Discov Oncol2026https://conductscience.org/library/papers/42035369PubMed
41907432Regulatory BC200 RNA promotes breast carcinogenesis by repressing BRCA1 gene expression.iScience2026https://conductscience.org/library/papers/41907432PubMed
41479036Epigenetic Modulation of Immunity: Mechanisms, Implications, and Emerging Therapeutic Horizons; a Step Toward Epigenetics to Precision.Subcell Biochem2026https://conductscience.org/library/papers/41479036PubMed
41108105Epithelial-mesenchymal-associated non-coding RNAs as Breast cancer metastasis biomarkers.Cell Cycle2025https://conductscience.org/library/papers/41108105PubMed
41020915Unveiling the oncogenic functions of lncRNA PSMG3-AS1: a review of its biological roles in cancer.Discov Oncol2025https://conductscience.org/library/papers/41020915PubMed
40869000The Interplay Between Oxidant/Antioxidant System, Transcription Factors, and Non-Coding RNA in Lung Cancer.Int J Mol Sci2025https://conductscience.org/library/papers/40869000PubMed
40553231Exosomal long non-coding RNAs in human malignancies: biological functions and clinical applications.Med Oncol2025https://conductscience.org/library/papers/40553231PubMed
40281701Current Research in Drug-Free Cancer Therapies.Bioengineering (Basel)2025https://conductscience.org/library/papers/40281701PubMed
40257717Direct oral anticoagulants do not affect miR-27a-3p expression, a regulator of coagulation cascade, in atrial fibrillation patients.J Thromb Thrombolysis2025https://conductscience.org/library/papers/40257717PubMed
40255569MiR-3613-5p targets AQP4 to promote the progression of chronic atrophic gastritis to gastric cancer.Front Pharmacol2025https://conductscience.org/library/papers/40255569PubMed
40202675Regulation of immune-mediated chemoresistance in cancer by lncRNAs: an in-depth review of signaling pathways.Naunyn Schmiedebergs Arch Pharmacol2025https://conductscience.org/library/papers/40202675PubMed
40202565Interplay between LncRNAs and autophagy-related pathways in leukemia: mechanisms and clinical implications.Med Oncol2025https://conductscience.org/library/papers/40202565PubMed
40046513The Common Hallmarks and Interconnected Pathways of Aging, Circadian Rhythms, and Cancer: Implications for Therapeutic Strategies.Research (Wash D C)2025https://conductscience.org/library/papers/40046513PubMed
40006021Cellular Epigenetic Targets and Epidrugs in Breast Cancer Therapy: Mechanisms, Challenges, and Future Perspectives.Pharmaceuticals (Basel)2025https://conductscience.org/library/papers/40006021PubMed
39849644Dysregulation of transposable elements and PIWI-interacting RNAs in myelodysplastic neoplasms.Biomark Res2025https://conductscience.org/library/papers/39849644PubMed
39811361Eugenol inhibits NEAT1 as a ceRNA in pre-cancerous breast lesions.Heliyon2025https://conductscience.org/library/papers/39811361PubMed

See all 22 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39149142

GET https://conductscience.org/api/papers/v1/39149142/references?page=2